Autonomix Medical, Inc. to Present at the Virtual Investor Event Titled “A Breakthrough Medical Device for the Diagnosis and Treatment of Diseases of the Nervous System”
06. Dezember 2023 14:00 ET
|
Autonomix Medical, Inc.
Live moderated video webcast on Monday, December 11 at 2:00 PM ET THE WOODLANDS, TX, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device...
Tulathromycin Market to Reach USD 457.82 Million by 2030: Straits Research
08. April 2022 08:00 ET
|
Straits Research
New York, United States, April 08, 2022 (GLOBE NEWSWIRE) -- The tulathromycin market had a market share of USD 265.72 million in 2020, according to the new report of Straits Research. It is...